CARBAMAZEPINE

NDC 43353-953 · Aphena Pharma Solutions - Tennessee, LLC

Generic nameCARBAMAZEPINE

Dosage formTABLET

RouteORAL

Active ingredient(s)CARBAMAZEPINE

Strength200 mg/1

Pharmacologic classCytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]

Marketing categoryANDA

Packages

43353-953-53 — 60 TABLET in 1 BOTTLE (43353-953-53)

43353-953-60 — 90 TABLET in 1 BOTTLE (43353-953-60)

43353-953-80 — 180 TABLET in 1 BOTTLE (43353-953-80)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

30698-419 — Carbamazepine, 30698-421 — Carbamazepine, 30698-423 — Carbamazepine, 35561-355 — carbamazepine, 35561-356 — carbamazepine, 35561-357 — carbamazepine, 42806-274 — Carbamazepine, 42806-275 — Carbamazepine, 42806-276 — Carbamazepine, 43063-328 — Carbamazepine, 46708-420 — Carbamazepine, 46708-421 — Carbamazepine, 46708-422 — Carbamazepine, 46708-731 — CARBAMAZEPINE, 50090-0384 — Carbamazepine, 50090-5740 — Carbamazepine, 50268-160 — CARBAMAZEPINE, 50268-170 — Carbamazepine, 50268-171 — Carbamazepine, 50268-172 — Carbamazepine, +134 more

Poisoning, adverse-effect and underdosing codes for this drug

The ICD-10-CM Table of Drugs and Chemicals carries these diagnosis codes for this drug — a drug-name match derived from FDA's product name and the Table of Drugs and Chemicals, not a CMS-published pairing.

T42.1X1 — Poisoning by iminostilbenes, accidental (unintentional), T42.1X2 — Poisoning by iminostilbenes, intentional self-harm, T42.1X3 — Poisoning by iminostilbenes, assault, T42.1X4 — Poisoning by iminostilbenes, undetermined, T42.1X5 — Adverse effect of iminostilbenes, T42.1X6 — Underdosing of iminostilbenes

From the FDA National Drug Code Directory, retrieved 2026-08-24. Product listings are submitted by labelers; FDA does not verify them.